Risk Factors Associated With Microbiological and Clinical Failure The group with persistent bacteremia showed a trend, though not statistically significant, toward initiating a dosing interval of 8–12 hours rather than 6 hours, compared with the nonpersistent bacteremia group (Table, Supplemental Digital Content 2, https://links.lww.com/INF/G209 ).
← all excerpts
Optimal Vancomycin AUC Target in Pediatric MRSA Bacteremia: A Bayesian-guided Approach.
1
—
—